Table 3.
Acute cardiovascular care unit procedures and medical therapies.
| All Patients (n = 239) | STEMI Patients (n = 190) | NSTEMI Patients (n = 49) | p Value | |
|---|---|---|---|---|
| Procedures and treatments | ||||
| Mechanical ventilation | ||||
| Invasive | 152 (63.6) | 115 (60.5) | 37 (75.5) | 0.052 |
| Non-invasive | 30 (12.6) | 22 (11.6) | 8 (16.3) | 0.371 |
| Inotropes | 222 (92.9) | 173 (91.1) | 49 (100) | 0.027 |
| Red blood cells transfusion | 28 (11.7) | 18 (9.5) | 10 (20.4) | 0.034 |
| Temporary pacemaker | 31 (13) | 28 (14.7) | 3 (6.1) | 0.152 |
| Pulmonary artery catheter | 52 (21.8) | 39 (20.5) | 13 (26.5) | 0.364 |
| Renal replacement therapy | 12 (5.0) | 6 (3.2) | 6 (12.2) | 0.009 |
| Ventricular assist devices | 0.506 | |||
| IABP | 107 (44.8) | 83 (43.7) | 24 (49.0) | 0.146 |
| Impella CP | 14 (5.9) | 9 (4.7) | 5 (10.2) | 0.210 |
| ECMO | 9 (3.8) | 9 (4.7) | 0 | 0.027 |
| Pharmacological treatment | ||||
| Dobutamine/dopamine | 185 (77.4) | 146 (76.8) | 39 (79.5) | 0.682 |
| Epinephrine | 40 (16.7) | 33 (17.3) | 7 (14.2) | 0.266 |
| Nitrates | 101 (42.2) | 74 (38.9) | 27 (55.1) | 0.041 |
| Nitroprusside | 14 (5.8) | 12 (6.3) | 2 (4.0) | 0.741 |
| Other vasodilators | 37 (15.4) | 31 (16.3) | 6 (12.2) | 0.482 |
| Diuretics | 152 (63.5) | 114 (60.0) | 38 (77.5) | 0.023 |
| Aspirin | 200 (83.6) | 156 (82.1) | 44 (89.7) | 0.194 |
| P2Y12 inhibitors | 178 (74.4) | 137 (72.1) | 41 (83.6) | 0.098 |
| Clopidogrel | 160 (66.9) | 121 (63.6) | 39 (79.5) | 0.035 |
| Prasugrel | 27 (11.2) | 24 (12.6) | 3 (6.1) | 0.310 |
| Ticagrelor | 8 (3.3) | 6 (3.1) | 2 (4.0) | 0.669 |
| Glycoprotein IIb/IIIa inhibitors | 30 (12.5) | 27 (14.2) | 3 (6.1) | 0.152 |
| Any heparin | 187 (78.2) | 146 (76.8) | 41 (83.6) | 0.301 |
| Low-molecular-weight heparin | 70 (29.2) | 56 (29.4) | 14 (28.5) | 0.902 |
| Unfractionated heparin | 159 (66.5) | 124 (65.2) | 35 (71.4) | 0.415 |
| Amiodarone | 66 (27.6) | 51 (26.8) | 15 (30.6) | 0.599 |
| Lidocaine | 25 (10.4) | 25 (13.1) | 0 | 0.003 |
| Other antiarrhythmic drugs | 3 (1.2) | 3 (1.5) | 0 | 1 |
| Digoxin | 17 (7.1) | 14 (7.3) | 3 (6.1) | 1 |
| ACEIs/ARBs | 95 (39.7) | 79 (41.5) | 16 (32.6) | 0.255 |
| β-Blockers | 52 (21.7) | 35 (18.4) | 17 (34.6) | 0.014 |
| Calcium channel blockers | 18 (7.5) | 17 (8.9) | 1 (2.0) | 0.133 |
| Statins | 132 (55.2) | 97 (51.0) | 35 (71.4) | 0.011 |
Values are given as n (%). STEMI, ST-segment elevation myocardial infarction; NSTEMI, non-ST-segment elevation myocardial infarction; IABP, intra-aortic balloon pump; ECMO, extracorporeal membrane oxygenation; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker.